The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with HSJD 2017
In 2017, Invest for children has made a donation to Children’s Hospital Sant Joan de Déu of Barcelona, with the aim to continue with the research of children’s diseases. Most…
see project 